AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Suitglip-M XR 100/1000 Tablet

Prescription Icon
Prescription Required

Marketer

Ipca Laboratories Ltd

Salt Composition

Sitagliptin (100mg) + Metformin (1000mg)

Overview Suitglip-M XR 100/1000 Tablet

Glimepiride-Metformin extended-release 100/1000 mg tablets combine two agents to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate serious diabetic complications like nephropathy and retinopathy, potentially lessening the risk of cardiovascular events. This medication may be administered independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glycemic control, and concurrent medications. Consuming the tablet with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise regimen is crucial for effective diabetes management. Commonly reported side effects include diarrhea, nausea, vomiting, dyspepsia, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; patients should be educated on its recognition and management. This medication isn't universally suitable. Prior to initiating treatment, inform your physician of any history of renal, hepatic, or cardiac disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating individuals require medical consultation before use. Interactions with other medications are possible; disclose all current medications to ensure safety. Alcohol intake should be minimized due to its hypoglycemic effect. Your doctor will monitor renal function and blood glucose levels throughout treatment.

Uses of Suitglip-M XR 100/1000 Tablet

Managing type 2 diabetes

Major Benefits of Suitglip-M XR 100/1000 Tablet:

Always follow your doctor's instructions or refer to the product label for proper administration. Consume Suitglip-M XR 100/1000 Tablets with a meal.

Common Side effects of Suitglip-M XR 100/1000 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Suitglip-M XR 100/1000 Tablet:

Follow your physician's instructions or consult the product label for proper administration. Consume Suitglip-M XR 100/1000 tablets with a meal.

How Suitglip-M XR 100/1000 Tablet works:

Suitglip-M XR 100/1000 tablets combine sitagliptin and metformin to manage blood glucose. Sitagliptin boosts insulin production by the pancreas, improves insulin utilization, and lessens hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Suitglip-M XR 100/1000 tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Suitglip-M XR 100/1000 tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Suitglip-M XR 100/1000 tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Suitglip-M XR 100/1000 Tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. The medication is contraindicated in those with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

The use of Suitglip-M XR 100/1000 tablets is likely contraindicated in individuals with hepatic impairment and should be omitted. Physician consultation is recommended.

What if you forget to take Suitglip-M XR 100/1000 Tablet :

Should you forget a Suitglip-M XR 100/1000 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Suitglip-M XR 100/1000 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Suitglip-M XR 100/1000 Tablet

Suitglip-M XR 100/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged use of Suitglip-M XR 100/1000 tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Suitglip-M XR 100/1000 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Suitglip-M XR 100/1000 Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Suitglip-M XR 100/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitagliptin/Metformin (Suitglip-M XR 100/1000) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding this medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Suitglip-M XR 100/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Suitglip-M XR 100/1000 Tablet may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Patients with allergies to Suitglip-M XR 100/1000 Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Suitglip-M XR 100/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Suitglip-M XR 100/1000) can cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency due to excessive blood lactic acid. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Suitglip-M XR 100/1000 Tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Suitglip-M XR 100/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Suitglip-M XR 100/1000 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Suitglip-M XR 100/1000 Tablet components or excipients should not use it. This medication is contraindicated in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Suitglip-M XR 100/1000 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Suitglip-M XR 100/1000) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Suitglip-M XR 100/1000 tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication; ensure it's inaccessible to children, pets, and others.
Suitglip-M XR 100/1000 Ta...
137
MRP 159
14% off